Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robledo

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Hormone Research in Paediatrics|November 27, 2025
EndoCompass Project: Research Roadmap for Adrenal and Cardiovascular EndocrinologyEystein S Husebye, Guillaume Assié, Nils Krone, et al.
Molecular Cancer|August 9, 2023
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trialJavier Martin-Broto, Claudia Valverde, Nadia Hindi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and ParagangliomasLucie Evenepoel, Francien H van Nederveen, Lindsey Oudijk, et al.
Thyroid : Official Journal of the American Thyroid Association|March 6, 2025
DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid CancerHelena Rodríguez-Lloveras, Carles Zafon, Carmela Iglesias, et al.
Human Molecular Genetics|March 6, 2016
Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expressionJoel Smith, Martin L Read, Jon Hoffman, et al.
The Journal of Experimental Medicine|April 13, 2019
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and <i>BRAF</i> <sup></sup> mutationSusana García-Silva, Alberto Benito-Martín, Sara Sánchez-Redondo, et al.
Journal of the National Cancer Institute|March 14, 2015
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma geneAlberto Cascón, Iñaki Comino-Méndez, María Currás-Freixes, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2013
DNA methylation signatures identify biologically distinct thyroid cancer subtypesSandra Rodríguez-Rodero, Agustín F Fernández, Juan Luís Fernández-Morera, et al.
The Journal of Experimental Medicine|April 24, 2019
Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and <i>BRAF</i> <sup></sup> mutationSusana García-Silva, Alberto Benito-Martín, Sara Sánchez-Redondo, et al.
European Journal of Endocrinology|January 13, 2025
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumorsKatharina Wang, Alessa Fischer, Umberto Maccio, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Hormone Research in Paediatrics|November 27, 2025
EndoCompass Project: Research Roadmap for Adrenal and Cardiovascular EndocrinologyEystein S Husebye, Guillaume Assié, Nils Krone, et al.
Molecular Cancer|August 9, 2023
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trialJavier Martin-Broto, Claudia Valverde, Nadia Hindi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and ParagangliomasLucie Evenepoel, Francien H van Nederveen, Lindsey Oudijk, et al.
Thyroid : Official Journal of the American Thyroid Association|March 6, 2025
DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid CancerHelena Rodríguez-Lloveras, Carles Zafon, Carmela Iglesias, et al.
Human Molecular Genetics|March 6, 2016
Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expressionJoel Smith, Martin L Read, Jon Hoffman, et al.
The Journal of Experimental Medicine|April 13, 2019
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and <i>BRAF</i> <sup></sup> mutationSusana García-Silva, Alberto Benito-Martín, Sara Sánchez-Redondo, et al.
Journal of the National Cancer Institute|March 14, 2015
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma geneAlberto Cascón, Iñaki Comino-Méndez, María Currás-Freixes, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2013
DNA methylation signatures identify biologically distinct thyroid cancer subtypesSandra Rodríguez-Rodero, Agustín F Fernández, Juan Luís Fernández-Morera, et al.
The Journal of Experimental Medicine|April 24, 2019
Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and <i>BRAF</i> <sup></sup> mutationSusana García-Silva, Alberto Benito-Martín, Sara Sánchez-Redondo, et al.
European Journal of Endocrinology|January 13, 2025
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumorsKatharina Wang, Alessa Fischer, Umberto Maccio, et al.
Pageof 22